Patents by Inventor Simone ORLICH

Simone ORLICH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
    Patent number: 9873714
    Abstract: The present invention relates to processes for preparing a glucopyranosyl-substituted benzyl-benzene derivative of general formula III, wherein R1 is defined according to claim 1.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: January 23, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dirk Weber, Tobias Fiedler, Christian Filser, Rainer Hamm, Simone Orlich, Matthias Post, Svenja Renner, Xiao-Jun Wang, Thomas Wirth
  • PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES
    Publication number: 20150218200
    Abstract: The present invention relates to processes for preparing a glucopyranosyl-substituted benzyl-benzene derivative of general formula III, wherein R1 is defined according to claim 1.
    Type: Application
    Filed: April 7, 2015
    Publication date: August 6, 2015
    Inventors: Dirk WEBER, Tobias FIEDLER, Christian FILSER, Rainer HAMM, Simone ORLICH, Matthias POST, Svenja RENNER, Xiao-Jun WANG, Thomas WIRTH
  • Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
    Patent number: 9024010
    Abstract: The present invention relates to processes for preparing a glucopyranosyl-substituted benzyl-benzene derivative of general formula III, wherein R1 is defined according to claim 1.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: May 5, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dirk Weber, Tobias Fiedler, Christian Filser, Rainer Hamm, Simone Orlich, Matthias Post, Svenja Renner, Xiao-Jung Wang, Thomas Wirth
  • Method for the preparation of a crystalline form
    Patent number: 8802842
    Abstract: The invention relates to a method for the preparation for a crystalline form of 1-chloro-4-(?-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene. In addition the invention relates to a crystalline form obtainable by this method, to a pharmaceutical composition and to the use thereof for preparing medicaments.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: August 12, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dirk Weber, Svenja Renner, Tobias Fiedler, Simone Orlich
  • PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES
    Publication number: 20110237789
    Abstract: The present invention relates to processes for preparing a glucopyranosyl-substituted benzyl-benzene derivative of general formula III, wherein R1 is defined according to claim 1.
    Type: Application
    Filed: September 28, 2010
    Publication date: September 29, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Dirk WEBER, Tobias FIEDLER, Christian FILSER, Rainer HAMM, Simone ORLICH, Matthias POST, Svenja RENNER, Xiao-Jun WANG, Thomas WIRTH
  • METHOD FOR THE PREPARATION OF A CRYSTALLINE FORM
    Publication number: 20110237526
    Abstract: The invention relates to a method for the preparation for a crystalline form of 1-chloro-4-(?-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene. In addition the invention relates to a crystalline form obtainable by this method, to a pharmaceutical composition and to the use thereof for preparing medicaments.
    Type: Application
    Filed: September 28, 2010
    Publication date: September 29, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Dirk Weber, Svenja Renner, Tobias Fiedler, Simone Orlich
  • Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
    Publication number: 20070173517
    Abstract: Disclosed is an improved multi-step process for preparing a compound of Formula I: wherein R1 to R3 are as defined herein. The compounds of formula I inhibit the binding of human intercellular adhesion molecules to the Leukointegrins. As a result, these compounds are useful in the treatment of inflammatory and immune cell-mediated diseases.
    Type: Application
    Filed: January 16, 2007
    Publication date: July 26, 2007
    Inventors: Thomas WIRTH, Jutta KROEBER, Thomas NICOLA, Armin RAPP, Dieter GUTHEIL, Simone ORLICH, Xiao-jun WANG, Dhileepkumar KRISHNAMURTHY